Janssen Pharmaceutica NV
www.janssenpharmaceutica.be
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Janssen Pharmaceutica NV
Coronavirus Update: Sanofi and GSK ‘Happy To Lose’ COVID-19 Vaccine Race
Heads of vaccines development at partners GSK and Sanofi:“This is not a sprint, it’s a marathon.”
J&J Taps Biological E For Up To 500m Coronavirus Vaccine Doses A Year
Johnson & Johnson has added a manufacturing base in India’s Biological E as part of a global supply chain for its COVID-19 vaccine candidate. While Biological E will make 400-500 million dosages for the US firm, it has licensed for development another SARS-CoV-2 vaccine candidate from US-based Baylor College of Medicine.
Company Information
- Industry
- Pharmaceuticals